Get started
Author

Lytske Jantien Bakker

Observed names: Bakker, Lytske, L J Bakker, L. J. Bakker, L.J Bakker, L.J. Bakker, Lytske Bakker, Lytske J. Bakker
Observed institutions: Utrecht University, University Medical Center Utrecht, National Institute for Public Health and the Environment, Tergooi, Jeroen Bosch Ziekenhuis, Erasmus University Rotterdam
ORCID: 0000-0001-8583-0115
Observed ORCID: 0000-0001-8583-0115
OpenAlex ID: A5017248751
An artificial intelligence based app for skin cancer detection evaluated in a population based setting
2023 · Anna M. Smak Gregoor, Tobias E. Sangers, et al. · npj Digital Medicine · 100
PDF
Nocardia asteroides pneumonia complicating low dose methotrexate treatment of refractory rheumatoid arthritis.
1991 · J.J Cornelissen, L.J Bakker, et al. · Annals of the Rheumatic Diseases · 43
PDF
Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
2022 · Cornelia C. H. Wielders, Leo M. Schouls, et al. · Antimicrobial Resistance and Infection Control · 41
PDF
Phagocytic Function of Monocyte-Derived Macrophages Is Not Affected by Human Immunodeficiency Virus Type 1 Infection
1993 · H. S. L. M. Nottet, L. de Graaf, et al. · The Journal of Infectious Diseases · 34
Molecular characteristics of carbapenemase-producing Enterobacterales in the Netherlands; results of the 2014–2018 national laboratory surveillance
2020 · K. van der Zwaluw, S. Witteveen, et al. · Clinical Microbiology and Infection · 32
PDF
Economic evaluations of big data analytics for clinical decision-making: a scoping review
2020 · Lytske Bakker, Jos Aarts, et al. · Journal of the American Medical Informatics Association · 31
PDF
Trends, seasonality and the association between outpatient antibiotic use and antimicrobial resistance among urinary bacteria in the Netherlands
2020 · Evelyn Pamela Martínez, Joost van Rosmalen, et al. · Journal of Antimicrobial Chemotherapy · 27
PDF
Attitudes Toward the Adoption of Remote Patient Monitoring and Artificial Intelligence in Parkinson’s Disease Management: Perspectives of Patients and Neurologists
2024 · Carlos Antonio Godoy Junior, Francesco Miele, et al. · Patient · 24
PDF
Antibiotic Resistance and the Risk of Recurrent Bacteremia
2017 · Sjoukje H S Woudt, Sabine C de Greeff, et al. · Clinical Infectious Diseases · 21
PDF
Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli
2013 · M. A. Leverstein-van Hall, K. Waar, et al. · Journal of Antimicrobial Chemotherapy · 19
Third-generation cephalosporin and carbapenem resistance in Streptococcus mitis/oralis. Results from a nationwide registry in the Netherlands
2018 · J. van Prehn, M.I. van Triest, et al. · Clinical Microbiology and Infection · 14
Down-Regulation of Human Immunodeficiency Virus Type I (HIV-1) Production after Stimulation of Monocyte-Derived Macrophages Infected with HIV-1
1993 · H. S. L. M. Nottet, L. de Graaf, et al. · The Journal of Infectious Diseases · 13
How can we discover the most valuable types of big data and artificial intelligence-based solutions? A methodology for the efficient development of the underlying analytics that improve care
2021 · Lytske Bakker, Jos Aarts, et al. · BMC Medical Informatics and Decision Making · 12
PDF
Analysing electronic health records: The benefits of target trial emulation
2021 · Lytske J. Bakker, Lucas M.A. Goossens, et al. · Health Policy and Technology · 10
PDF
Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections
1988 · A I Hoepelman, L J Bakker, et al. · Antimicrobial Agents and Chemotherapy · 10
The potential of real-time analytics to improve care for mechanically ventilated patients in the intensive care unit: an early economic evaluation
2020 · Lytske Bakker, Katerina Vaporidi, et al. · Cost Effectiveness and Resource Allocation · 9
PDF
Implementing a hospital-wide protocol for Staphylococcus aureus bacteremia
2018 · K. Bolhuis, L. J. Bakker, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 7
PDF
Healthcare problems cannot be solved using health technologies alone: The example of precision medicine
2018 · W. Ken Redekop, Lytske J. Bakker, et al. · Health Policy and Technology · 7
PDF
Clinical prevalence of collateral sensitivity: a systematic exploration of multicentre antimicrobial surveillance data
2026 · Sebastian T Tandar, Laura B Zwep, et al. · The Lancet Microbe · 6
European Cooperation on Healthcare
2019 · Donald RJ Singer, Lytske Bakker, et al. · Health Policy and Technology · 6
PDF
Diverse preferences, different solutions: Exploring remote monitoring preferences in Parkinson's disease through a discrete choice experiment
2025 · Carlos Antonio Godoy Junior, Laura Mäkitie, et al. · Journal of Parkinson s Disease · 4
Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study
2022 · Jara R. de la Court, Sjoukje H. S. Woudt, et al. · Annals of Clinical Microbiology and Antimicrobials · 4
PDF
False aminoglycoside resistance in Enterobacterales and non-fermenters by an automated testing system: a descriptive study
2023 · P. M. C. Klein Klouwenberg, W. Altorf–van der Kuil, et al. · Microbiology Spectrum · 3
Cost-effectiveness Analysis of Mirikizumab Versus Ustekinumab in Advanced Therapy Experienced Patients With Moderately to Severely Active Ulcerative Colitis in the Us
2024 · Xuan Wang, Lytske Bakker, et al. · Inflammatory Bowel Diseases · 2
PDF
Association between antimicrobial usage in livestock and antimicrobial resistance in Escherichia coli isolates from human urinary tract infections in the Netherlands, 2009–2020
2024 · Anouk P Meijs, Linda E Chanamé-Pinedo, et al. · Journal of Antimicrobial Chemotherapy · 1
PDF
Works count: 46
Citation count: 482
H-index: 12
I10-index: 15
Year
Topic
Type